home / stock / nmlsf / nmlsf news

NMLSF News and Press, Nova Mentis Life Science Corp From 03/15/22

Stock Information
Company Name: Nova Mentis Life Science Corp
Stock Symbol: NMLSF
Market: OTC
Website: novamentis.ca
Menu
NMLSF NMLSF Quote NMLSF Short NMLSF News NMLSF Articles NMLSF Message Board
Get NMLSF Alerts

News, Short Squeeze, Breakout and More Instantly...
NMLSF - Nova Mentis Announces Closing of Non-Brokered Financing

Nova Mentis Announces Closing of Non-Brokered Financing Canada NewsWire VANCOUVER, BC , March 15, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in fi...
NMLSF - Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism

Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism Canada NewsWire VANCOUVER, BC , Feb. 16, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and glo...

NMLSF - /R E P E A T - Nova Mentis and KGK Science Form Tactical Partnership/

/R E P E A T - Nova Mentis and KGK Science Form Tactical Partnership/ Canada NewsWire The Companies Plan to Jointly Submit a Psilocybin Clinical Trial Application to Health Canada VANCOUVER, BC , Jan. 27, 2022 /CNW/ - Nova Mentis Life Science Co...

NMLSF - Nova Mentis and KGK Science Form Tactical Partnership

Nova Mentis and KGK Science Form Tactical Partnership Canada NewsWire The Companies Plan to Jointly Submit a Psilocybin Clinical Trial Application to Health Canada VANCOUVER, BC , Jan. 27, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA...
NMLSF - Wellbeing Digital Sciences' Subsidiary KGK Science Forms Tactical Partnership with Nova Mentis

VANCOUVER, British Columbia, Jan. 27, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based healthcare company focused on innovative clinical solutions, artificial i...

NMLSF - Nova Mentis Provides Corporate Update - 2022 Planned Catalysts

Nova Mentis Provides Corporate Update - 2022 Planned Catalysts Canada NewsWire VANCOUVER, BC , Jan. 12, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader...

NMLSF - Nova Mentis Welcomes New CFO Rebecca Hudson

Nova Mentis Welcomes New CFO Rebecca Hudson Canada NewsWire VANCOUVER, BC , Dec. 31, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psil...
NMLSF - Nova Mentis Files Genetic Neuroinflammatory Disease Patent

Nova Mentis Files Genetic Neuroinflammatory Disease Patent Canada NewsWire Messenger RNA Diagnostic/Treatment Paradigm VANCOUVER, BC , Nov. 9, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Com...

NMLSF - Nova Mentis to Present at the Wonderland: Miami Psychedelic Conference

Nova Mentis to Present at the Wonderland: Miami Psychedelic Conference Canada NewsWire VANCOUVER, BC , Nov. 4, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global...

NMLSF - U.S. FDA Approves Nova Mentis Orphan Drug Application

U.S. FDA Approves Nova Mentis Orphan Drug Application Canada NewsWire Psilocybin Fragile X Syndrome Treatment VANCOUVER, BC , Nov. 2, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"...
Previous 10 Next 10